|
Quotes & Info
|
| ISIS > SEC Filings for ISIS > Form 8-K on 13-Feb-2013 | All Recent SEC Filings |
13-Feb-2013
Change in Directors or Principal Officers
On February 12, 2013, Dr. John C. Reed resigned as a member of the Board of Directors of Isis Pharmaceuticals, Inc. (the "Company") due to his commitments as Head of Roche Pharma Research and Early Development and as a member of Roche's Corporate Executive Committee.
Isis thanks Dr. Reed for his service.
Mr. Joseph H. Wender will replace Dr. Reed as a member of the Nominating, Governance and Review Committee of Isis' Board of Directors.
|
|